Health brief
Clinical Advances and Regional Health Operations
MediWound advances global trials for an enzymatic wound gel, Hadassah opens a European branch in Cyprus, and the Health Ministry issues public health advisories.
Health
MediWound's global trial tests whether pineapple enzymes can replace surgery for diabetic ulcers — setting up a non-invasive standard for chronic wound care.
BackgroundChronic non-healing wounds require debridement to clear dead tissue and prevent severe infections that lead to amputation. Enzymatic treatments aim to break down dead tissue selectively without damaging underlying healthy blood vessels.
- The global VALUE trial is recruiting 216 patients across medical centers in the United States, Europe, and Israel, expanding its clinical footprint.
- Prof. Josef Haik, head of Sheba Medical Center's Burn Center, leads clinical trial execution, highlighting Israeli leadership in advanced wound management.
- EscharEx utilizes enzymes extracted from pineapple stems to clean non-healing wound beds non-invasively, providing an alternative to surgical intervention.
Health
Hadassah's Limassol campus establishes its first EU physical foothold — turning Cyprus into a medical hub for Israeli clinical expertise.
BackgroundLeading academic medical centers build international outposts to capture medical tourism and offer second-opinion consultations. Cyprus serves as a convenient healthcare bridge linking Middle Eastern clinical expertise with European Union regulatory standards.
- The Limassol facility offers diagnostic imaging, physical rehabilitation, and outpatient clinics, establishing a physical EU foothold for the Jerusalem medical center.
- The campus directly connects European patients and Israeli expatriates with senior Israeli specialist physicians, streamlining international consultations.
- The expansion marks Hadassah's first direct hospital operation inside the EU, laying infrastructure for broader regional healthcare delivery.
Health
Health officials banned an illegal online weight-loss supplement containing sibutramine — exposing the persistent dangers of undeclared prescription drugs in online health markets.
BackgroundSibutramine was pulled from international markets after clinical trials revealed it significantly increases heart attack and stroke risks. Unregulated dietary supplements sold online often conceal dangerous prescription compounds to produce rapid weight loss.
- Laboratory testing by health officials revealed high concentrations of sibutramine in the unapproved product, raising immediate public safety concerns.
- The Health Ministry warned consumers that unregulated online supplements pose severe stroke and cardiac risks, urging immediate cessation of use.
- Enforcement agencies are acting to identify and shut down illicit digital sales channels distributing the dangerous product across Israel.
Health
Abnormal bacterial tests triggered a mandatory water boil advisory in Karmiel — forcing municipal utility crews into system-wide flushing to secure the local water supply.
BackgroundRoutine microbiological sampling across municipal water networks detects microbial contamination early to prevent widespread public health outbreaks. System flushing removes residual contaminants before secondary testing can recertify tap water as safe for consumption.
- The mandatory order mandates boiling water for drinking, cooking, and teeth brushing, while unboiled water remains safe for general domestic sanitation.
- Municipal utility crews are actively flushing supply lines to clear bacterial contamination from the distribution network, aiming for rapid safety clearance.
- Secondary water testing is required before the Health Ministry can lift the precautionary boil advisory for Karmiel residents.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
